MatriSys Bioscience is leading the discovery and clinical development of a novel class of biopharmaceuticals to transform the treatment of chronic skin diseases.
About Us
Our groundbreaking technology platform identifies beneficial bacteria derived from healthy human skin to potentially treat the millions of children and adults suffering from difficult to treat chronic skin diseases.
Our Platform
More than 230 million patients suffer from dermatological conditions such as atopic dermatitis, Netherton, acne and rosacea, and these diseases have a detrimental impact on patients’ quality of life. Our development approach is based on the topical application of products containing beneficial bacteria to restore skin homeostasis, of which disruption is a common characterization of these diseases.
Skin Microbiome
There is a huge unmet medical need in dermatology to reduce the use of steroids, immunosuppressants, and antibiotics. MatriSys is developing a deep pipeline to treat the millions of children and adults suffering from difficult to treat chronic skin diseases.
Our Programs
©2022 MatriSys Bioscience | Privacy Policy
